Morphologic subforms of ALCL and their correlation with immunophenotype
Histologic subform . | CD30 . | Immunophenotype . | EMA+cases . | ALK+ cases (%) . |
---|---|---|---|---|
Common (classic) type* 3,10 13 | Positive | Most T/null | Majority | 60-90 |
Giant cell-rich3,10 13 | Positive | Most T/null | Minority | 30-40 |
Small cell11 13 | Positive (mainly large cells) | T | Most† | 100 |
Lymphohistiocytic3,8,10 13 | Positive | T | Most† | 80-100 |
Hodgkin-like3,10,13 65 | Positive | Null (rarely T) | Minority | ∼ 15 |
Rare subforms | ||||
Sarcomatoid42 | Positive | NDA | NDA | NDA |
Neutrophil rich13,44 45 | ||||
Eosinophil rich43 | ||||
Signet ring15 46 |
Histologic subform . | CD30 . | Immunophenotype . | EMA+cases . | ALK+ cases (%) . |
---|---|---|---|---|
Common (classic) type* 3,10 13 | Positive | Most T/null | Majority | 60-90 |
Giant cell-rich3,10 13 | Positive | Most T/null | Minority | 30-40 |
Small cell11 13 | Positive (mainly large cells) | T | Most† | 100 |
Lymphohistiocytic3,8,10 13 | Positive | T | Most† | 80-100 |
Hodgkin-like3,10,13 65 | Positive | Null (rarely T) | Minority | ∼ 15 |
Rare subforms | ||||
Sarcomatoid42 | Positive | NDA | NDA | NDA |
Neutrophil rich13,44 45 | ||||
Eosinophil rich43 | ||||
Signet ring15 46 |